DSpace

DSpace at RU >

Search Results

 
for  

Results 1-50 of 70.

Sort items by In order  |  Results/Page Authors/record

Item hits:

Full TextIssue DateTitleAuthor(s)
2012Current perspectives to overcome a positive crossmatch in living donor renal transplantation.Hilbrands, L.B.
2012Idiopathic giant oesophageal ulcer and leucopoenia after renal transplantationBoekel, G.A.J van; Volbeda, M.; van den Hoogen, M.W.; Hilbrands, L.B.; Berden, J.H.
2012Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.Hoogen, M.W.F. van den; Hoitsma, A.J.; Hilbrands, L.B.
2012In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells.Kamburova, E.G.; Koenen, H.J.P.M.; Boon, L.; Hilbrands, L.B.; Joosten, I.
2012Effect of mild diarrhea on tacrolimus exposureBoekel, G.A.J van; Aarnoutse, R.E.; van der Heijden, J.J.; Hoogtanders, K.E.; Hilbrands, L.B.
2012Effect of administration of apoptotic blebs on disease development in lupus mice.Fransen, J.H.; Berden, J.H.M.; Koeter, C.M.; Adema, G.J.; Vlag, J. van der; Hilbrands, L.B.
2011Een zaak van p(l)assen en metenHilbrands, L.B.
2011What to do with a failed renal allograft: take it or leave it?Gommers, D.G.; Hilbrands, L.B.
2011European society for organ transplantation advisory committee recommendations on generic substitution of immunosuppressive drugs.Gelder, T. van; Åsberg, A.; Barrou, B.; Budde, K.; Cattaneo, D.; Dudley, C.; Durlik, M.; Ekberg, H.; Fehr, T.; Boira, J.G.; Hartmann, A.; Hilbrands, L.B.; Kuypers, D.R.; Meur, Y.; MacPhee, I.; Marquet, P.; Metselaar, H.; Mota, A.; Serón, D.; Squifflet, J.P.
2011Nephrotic syndrome induced by pamidronateDam, M.A. ten; Hilbrands, L.B.; Wetzels, J.F.M.
2011Use of monoclonal antibodies in renal transplantationvan den Hoogen, M.W.; Hilbrands, L.B.
2011Synchronized turbo apoptosis induced by cold-shockFransen, J.H.; Dieker, J.W.C.; Hilbrands, L.B.; Berden, J.H.M.; van der Vlag, J.
2010Single-dose rituximab as induction in renal transplantation.Hoogen, M.W.F. van den; Hilbrands, L.B.
2010The role of dendritic cells in the pathogenesis of systemic lupus erythematosus.Fransen, J.H.; Vlag, J. van der; Ruben, J.; Adema, G.J.; Berden, J.H.M.; Hilbrands, L.B.
2010Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.Jacobs, J.F.M.; Punt, C.J.A.; Lesterhuis, W.J.; Sutmuller, R.P.M.; Brouwer, H.M.; Scharenborg, N.M.; Klasen, I.S.; Hilbrands, L.B.; Figdor, C.G.; Vries, I.J.M. de; Adema, G.J.
2009Immunotherapy with regulary T-cells in transplantation.Peters, J.H.; Koenen, H.J.P.M.; Hilbrands, L.B.; Joosten, I.
2009More on B-cell-depleting induction therapy and acute cellular rejection.Hoogen, M.W.F. van den; Hilbrands, L.B.
2009Urinary albumin-total protein ratio: a new diagnostic tool to differentiate glomerular from nonglomerular hematuria?Peters, H.P.E.; Hilbrands, L.B.
2009Both early and late apoptotic blebs are taken up by DC and induce IL-6 production.Fransen, J.H.; Hilbrands, L.B.; Jacobs, C.W.M.; Adema, G.J.; Berden, J.H.M.; Vlag, J. van der
2009Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.Fransen, J.H.; Hilbrands, L.B.; Ruben, J.; Stoffels, M.; Adema, G.J.; Vlag, J. van der; Berden, J.H.M.
2009Use of the platelet function analyzer to minimize bleeding complications after renal biopsy.Hoogen, M.W.F. van den; Verbruggen, H.W.; Polenewen, R.; Hilbrands, L.B.; Novakova, I.R.O.
2009Limited sampling strategies drawn within 3 hours postdose poorly predict mycophenolic acid area-under-the-curve after enteric-coated mycophenolate sodium.Winter, B.C. de; Gelder, T. van; Mathôt, R.A.A.; Glander, P.; Tedesco-Silva, H.; Hilbrands, L.B.; Budde, K.; Hest, R.M. van
2008Response to letter to the editor.Hendriks, M.P.; Sevaux, R.G.L. de; Hilbrands, L.B.
2008Reduced exposure to calcineurin inhibitors in renal transplantation.Hoogen, M van den; Hilbrands, L.B.
2008Glomerular haematuria: not so benign?Peters, H.P.E.; Hilbrands, L.B.; Wetzels, J.F.M.
2008Causes of frequency and nocturia after renal transplantationWeide, M.J.A. van der; Achterberg, T. van; Smits, J.P.J.M.; Heesakkers, J.P.F.A.; Bemelmans, B.L.H.; Hilbrands, L.B.
2008Encapsulating peritoneal sclerosis in patients on peritoneal dialysis.Hendriks, M.P.; Sevaux, R.G.L. de; Hilbrands, L.B.
2008Causes of frequency and nocturia after renal transplantation.Weide, M.J.A. van der; Achterberg, T. van; Smits, J.P.; Heesakkers, J.P.F.A.; Bemelmans, B.L.H.; Hilbrands, L.B.
2008Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy.Peters, J.H.; Hilbrands, L.B.; Koenen, H.J.P.M.; Joosten, I.
2008Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation.Peters, J.H.; Preijers, F.W.M.B.; Woestenenk, R.; Hilbrands, L.B.; Koenen, H.J.P.M.; Joosten, I.
2008Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus.Kreijveld, E.; Koenen, H.J.P.M.; Cranenbroek, B. van; Rijssen, E. van; Joosten, I.; Hilbrands, L.B.
2008Population pharmacokinetics of mycophenolic acid : a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients.Winter, BC de; Gelder, T van; Glander, P.; Cattaneo, D.; Tedesco-Silva, H.; Neumann, I.; Hilbrands, L.B.; Hest, RM van; Pescovitz, M.D.; Budde, K.; Mathot, R.A.
2007[Two patients with Eisenmenger syndrome treated with novel agents that target vasodilation of the pulmonary capillary bed]Hilbrands, L.B.; Wetzels, J.F.M.
2007KIR gene and KIR ligand analysis to predict graft rejection after renal transplantation.Kreijveld, E.; Meer, A. van der; Tijssen, H.J.; Hilbrands, L.B.; Joosten, I.
2007Following anti-CD25 treatment, a functional CD4+CD25+ regulatory T-cell pool is present in renal transplant recipients.Kreijveld, E.; Koenen, H.J.P.M.; Klasen, I.S.; Hilbrands, L.B.; Joosten, I.
2007Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity.Coenen, J.J.A.; Koenen, H.J.P.M.; Emmer, P.M.; Rijssen, E. van; Hilbrands, L.B.; Joosten, I.
2007Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.Coenen, J.J.A.; Koenen, H.J.P.M.; Rijssen, E. van; Kasran, A.; Boon, L.; Hilbrands, L.B.; Joosten, I.
2007The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.Kreijveld, E.; Hilbrands, L.B.; Berkel, Y. van; Joosten, I.; Allebes, W.A.
2007The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+ CD25- T cells.Kreijveld, E.; Koenen, H.J.P.M.; Hilbrands, L.B.; Hooff, H.J. van; Joosten, I.
2006Long-term outcome of renal transplantation from older donors.Hilbrands, L.B.; Wetzels, J.F.M.
2006Alternaria infectoria phaeohyphomycosis in a renal transplant patient.Nulens, E.; Laere, E. De; Vandevelde, H.; Hilbrands, L.B.; Rijs, A.J.M.M.; Melchers, W.J.G.; Verweij, P.E.
2006CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.Coenen, J.J.A.; Koenen, H.J.P.M.; Rijssen, E. van; Boon, L.; Joosten, I.; Hilbrands, L.B.
2006Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.Coenen, J.J.A.; Koenen, H.J.P.M.; Rijssen, E. van; Hilbrands, L.B.; Joosten, I.
2006Diagnostic approach in patients with asymptomatic haematuria: efficient or not?Huussen, J.; Koene, R.A.P.; Meuleman, E.J.H.; Hilbrands, L.B.
2006Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism.Straathof-Galema, L.; Wetzels, J.F.M.; Dijkman, H.B.P.M.; Steenbergen, E.; Hilbrands, L.B.
2006Ex vivo expansion of human CD4+ CD25high regulatory T cells from transplant recipients permits functional analysis of small blood samples.Kreijveld, E.; Koenen, H.J.P.M.; Hilbrands, L.B.; Joosten, I.
2006Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness.Emmer, P.M.; Vlag, J. van der; Adema, G.J.; Hilbrands, L.B.
2006Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.Hoitsma, A.J.; Hilbrands, L.B.
2005Screening for microalbuminuria.Hilbrands, L.B.; Huysmans, F.T.M.; Wetzels, J.F.M.
2005Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection.Hilbrands, L.B.; Hoitsma, A.J.; Wetzels, J.F.M.

1 2 next

 

  DSpace Software Copyright © 2002-2011  Duraspace - Feedback